Medical management of ascites in hepatic cirrhosis.
D000293:Adolescent; D000328:Adult; D000628:Aminophylline / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy / Q000628:therapy*; D002681:China; D004039:Diet, Sodium-Restricted; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000628:therapy*; D008109:Liver Diseases, Parasitic / Q000150:complications*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D012552:Schistosomiasis / Q000150:complications*; D013148:Spironolactone / Q000627:therapeutic use
D045930:Anabolic Agents; D006852:Hydrochlorothiazide; D013148:Spironolactone; D000628:Aminophylline